India revokes Roche’s Valcyte patent

May 19, 2010
Sales and Marketing India, Roche, patents

Indian authorities have revoked a patent granted in 2007 for Roche’s brand Valcyte, saying it had been wrongly granted.The decision was welcomed …

Pfizer takes the axe to manufacturing operations

May 19, 2010
Manufacturing and Production Pfizer, job cuts, manufacturing

Pfizer is to reduce manufacturing staffing by around 6,000 – around 18% of its total production workforce – and close …

Chiltern Announces new Offices and Expansion Plans in Asia Pacific

May 19, 2010
Research and Development

This builds further upon Chiltern’s well established operation in India. Chiltern is also in the process of forming a company …

UCB’s Roch Doliveux joins Innovative Medicines Initiative board

May 19, 2010
Research and Development UCB, appointment, research and development

UCB’s chief executive Roch Doliveux has joined the governing board of the Innovative Medicines Initiative. The IMI is a public-private …

Spain to cut prescription drug prices

May 19, 2010
Sales and Marketing Spain, industry, prices

The Spanish government will cut the prices of patented prescription drugs from 1 August in a bid to save 1.3 …

New healthcare marketing services firm launched

May 19, 2010
Medical Communications, Sales and Marketing PharmaGems, market research, marketing

A new business aimed at helping entrepreneurs and run by two former directors of Synovate Healthcare has launched in London. …

FerringSteveHowson

Steve Howson to lead Ferring UK

May 18, 2010
Research and Development, Sales and Marketing Ferring, appointment, research and development, sales and marketing

Ferring UK has appointed Steve Howson as its new general manager. He will have responsibility for operations in the UK …

SallyDavies

UK appoints interim chief medical officer

May 18, 2010
NHS, UK, appointment

Professor Dame Sally Davies will take on the role of interim chief medical officer when Sir Liam Donaldson retires as …

EMA eyes stem cell research breakthrough

May 18, 2010
Research and Development EMA, Stem cells, stem cell

European regulators are readying themselves to deal with the region’s first marketing authorisation application for a stem cell product. The …

Pfizer signs ground-breaking academic research deal

May 18, 2010
Research and Development Pfizer, US, academia, clinical research

Pfizer is teaming up with academia in a five-year bid to discover new uses for existing compounds. The pharma manufacturer …

Bayer opens US ‘science hub’

May 18, 2010
Research and Development Bayer, US, acdemia, clinical research

Bayer Schering Pharma has expanded its global research network, opening a new Innovation Center in San Francisco. The US centre …

Merck’s Brinavess performs in phase III

May 18, 2010
Research and Development Brinavess, Merck & Co, atrial fibrilation

Merck & Co’s heart disorder drug Brinavess has proved superior to rival amiodarone in reducing rates of atrial fibrillation in …

Lansley warns of deeper NHS cuts

May 17, 2010
NHS, NHS funding, election, government

Health Secretary Andrew Lansley has warned the NHS may face deeper cuts than expected. Lansley, who was appointed Health Secretary …

FDA says rotavirus vaccines are safe

May 17, 2010
Manufacturing and Production drug safety, rotarix, rotateq

The US Food and Drug Administration has taken the advice of its advisors and given its backing to resume the …

New global ‘polypill’ trials start

May 17, 2010
Research and Development Dr Reddy, hypertension, polypill, statin

New trials of a daily polypill – combining aspirin, a statin and two blood pressure lowering medicines – are underway …

Takeda plans cuts, eyes mergers

May 17, 2010
Research and Development, Sales and Marketing Takeda, job cuts

Takeda is planning to cut its workforce by 10% through a series of cuts that will predominantly be made to …

OSI Pharmaceuticals

Astellas set to acquire OSI Pharmaceuticals for $4bn

May 17, 2010
Research and Development, Sales and Marketing Astellas, M&A, MA, OSI

After four months and several failed bids Astellas Pharma has signed a definitive merger agreement with US biotech firm OSI …

What is Digital Marketing?

May 14, 2010
Medical Communications

Some consider it just another channel to market, but the reality is more complicated.by Mark Millar, PraeMedica

Blog footer

Digital Pharma: No breakthrough, but UK’s digital issues out in the open

May 14, 2010
Medical Communications Code of Practice, PMCPA, digi, digital, pm society

The UK’s Code of Practice regulator will produce guidance for pharma on digital marketing, but is reluctant to make formal …

The Gateway to Local Adoption Series

Latest content